Efficacy of a 5-day extended therapy program during lactation with cephapirin sodium in dairy cows chronically infected with Staphylococcus aureus

Canadian Veterinary Journal

Volumn 50, Issue 12, 2009, Pages 1257-1262

  Roy, Jean Philippe ^a   DesCôteaux, Luc ^a   DuTremblay, Denis ^a   Beaudry, Francis ^a   Johanne, Elsener ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Wyeth Animal Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFAPIRIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BOVINE MASTITIS; CANADA; CATTLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAIRYING; DRUG EFFECT; FEMALE; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CEPHAPIRIN; CHRONIC DISEASE; DAIRYING; FEMALE; MASTITIS, BOVINE; QUEBEC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); BOS; STAPHYLOCOCCUS AUREUS;

EID: 75449084927     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bradley AJ, Leach KA, Breen JE, Green MJ. Survey of the incidence and aetiology of mastitis on dairy farms in England and Wales, Vet Rec 2007; 160: 253-258.
2. Olde Riekerink RGM, Barkema HW, Kelton DF, Scholl DT. Incidence rate of clinical mastitis on Canadian dairy farms. J. Dairy Sci 2008; 91: 1366-1377.
3. Barkema HW, Schukken YH, Zadoks RN. Invited review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci 2006; 89: 1877-1895.
4. Shpigel NY, Kass PH, Saran A. A comparative randomized field trial on intramammary and intramuscular dry cow antibiotic treatment of subclinical Staphylococcus aureus mastitis in dairy cows. J Vet Med A 2006; 53: 418-422
5. Seegers H, Fourichon C, Beaudeau E Production effects related to mastitis and mastitis economics in dairy cattle herds. Vet Res 2003; 34: 475-491
6. Gillepsie BE, Moorehead H, Lunn P, et al. Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp and Staphylococcus aureus intramammary infections in lactating dairy cows. Vet Ther 2002; 3: 373-380.
7. Oliver SP, Gillepsie BE, Headrick ST, et al. Efficacy of extended ceftiofur intramammary therapy for treatment of subclinical mastitis in lactating dairy cows. J Dairy Sci 2004; 87: 2393-2400.
8. Deluyker HA, Van Oye SN, Boucher JF. Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows. J Dairy Sci 2005; 88: 604-614.
9. National Mastitis Council. Laboratory and Field Handbook on Bovine Mastitis. Fort Atkinson, Wisconsin: NMC, 1987.
10. Middleton JR, Luby CD. Escherichia coli mastitis in cattle being treated for Staphylococcus aureus intramammary infection. Vet Rec 2008; 162: 156-157.
11. Dingwell RT, Leslie KE, Duffield TF, et al. Efficacy of intramammary tilmicosin and risk factors for cure of Staphylococcus aureus infection in the dry period. J Dairy Sci 2003; 86: 159-168.
12. Sol J, Sampimon C, Snoep JJ. Factors associated with bacteriological cure after dry cow treatment of subclinical staphylococcal mastitis with antibiotics. J Dairy Sci 1994; 77: 75-79.
13. Sol J, Sampimon OC, Snoep JJ, Schukken YH. Factors associated with bacteriological cure during lactation after therapy for subclinical mastitis caused by Staphylococcus aureus. J Dairy Sci 1997; 80: 2803-2808.